Goro Fukami

724 total citations
15 papers, 549 citations indexed

About

Goro Fukami is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Goro Fukami has authored 15 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 6 papers in Cognitive Neuroscience and 4 papers in Clinical Psychology. Recurrent topics in Goro Fukami's work include Schizophrenia research and treatment (4 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Goro Fukami is often cited by papers focused on Schizophrenia research and treatment (4 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Goro Fukami collaborates with scholars based in Japan. Goro Fukami's co-authors include Kenji Hashimoto, Masaomi Iyo, Eiji Shimizu, Yukihiko Shirayama, Mihisa Fujisaki, Kaori Koike, Naoe Okamura, Tasuku Hashimoto, Nobuhisa Kanahara and Tetsuya Shiraishi and has published in prestigious journals such as Brain Research, Neuropharmacology and Clinica Chimica Acta.

In The Last Decade

Goro Fukami

15 papers receiving 538 citations

Peers

Goro Fukami

CMN

PMH

Markus Sack Germany

Hideaki Mitani Japan

Annarita Barone Italy

Michael L. Himes United States

Angelos Halaris United States

Alessandra Solida Switzerland

Ken Inada Japan

Anna Schuhmacher Germany

Brendon Binneman United States

Alexandra Soliman Canada

Markus Sack Germany

Goro Fukami

235 ×1.3

CMN

89 ×0.6

PMH

219 ×1.5

114 ×0.9

78 ×0.6

Citations per year, relative to Goro Fukami Goro Fukami (= 1×) peers Markus Sack

Countries citing papers authored by Goro Fukami

Since Specialization

Citations

This map shows the geographic impact of Goro Fukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Fukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Fukami more than expected).

Fields of papers citing papers by Goro Fukami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goro Fukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Fukami. The network helps show where Goro Fukami may publish in the future.

Co-authorship network of co-authors of Goro Fukami

This figure shows the co-authorship network connecting the top 25 collaborators of Goro Fukami. A scholar is included among the top collaborators of Goro Fukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goro Fukami. Goro Fukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Niitsu, Tomihisa, Mihisa Fujisaki, Akihiro Shiina, et al.. (2012). A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 32(5). 593–601. 35 indexed citations

Niitsu, Tomihisa, Yukihiko Shirayama, Daisuke Matsuzawa, et al.. (2011). Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(8). 1836–1840. 57 indexed citations

Haraguchi, Tadashi, Mihisa Fujisaki, Akihiro Shiina, et al.. (2011). Attitudes of Japanese psychiatrists toward forensic mental health as revealed by a national survey. Psychiatry and Clinical Neurosciences. 65(2). 150–157. 2 indexed citations

Haraguchi, Tadashi, et al.. (2011). Alterations of Responsibility Beliefs Through Cognitive-Behavioural Group Therapy for Obsessive-Compulsive Disorder. Behavioural and Cognitive Psychotherapy. 39(4). 481–486. 8 indexed citations

Fukami, Goro, Tasuku Hashimoto, Yukihiko Shirayama, et al.. (2010). Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects. Annals of General Psychiatry. 9(1). 37–37. 12 indexed citations

Fukami, Goro, et al.. (2010). A case of methamphetamine use disorder treated with the antibiotic drug minocycline. General Hospital Psychiatry. 32(5). 559.e1–559.e3. 26 indexed citations

Shiina, Akihiro, Yukihiko Shirayama, Tomihisa Niitsu, et al.. (2010). A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Annals of General Psychiatry. 9(1). 27–27. 71 indexed citations

Shirayama, Yukihiko, Katsumasa Muneoka, Makoto Fukumoto, et al.. (2010). Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats. Hippocampus. 21(10). 1105–1113. 55 indexed citations

Kanahara, Nobuhisa, Eiji Shimizu, Yoshimoto Sekine, et al.. (2009). Does hypofrontality expand to global brain area in progression of schizophrenia?: A cross-sectional study between first-episode and chronic schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(3). 410–415. 19 indexed citations

10.

Hashimoto, Tasuku, Eiji Shimizu, Kaori Koike, et al.. (2007). Deficits in auditory P50 inhibition in obsessive–compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(1). 288–296. 36 indexed citations

11.

Tomiya, Masayuki, Takeshi Fukushima, Hiroyuki Watanabe, et al.. (2007). Alterations in serum amino acid concentrations in male and female schizophrenic patients. Clinica Chimica Acta. 380(1-2). 186–190. 32 indexed citations

12.

Koike, Kazuhiko, Kenji Hashimoto, Goro Fukami, et al.. (2005). The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. Neuropharmacology. 48(3). 391–397. 17 indexed citations

13.

Shimizu, Eiji, Kenji Hashimoto, Shigehiro Ochi, et al.. (2005). Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits. Journal of Psychiatric Research. 41(1-2). 49–56. 28 indexed citations

14.

Fukami, Goro, Kenji Hashimoto, Kaori Koike, et al.. (2004). Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Research. 1016(1). 90–95. 112 indexed citations

15.

Hatta, Kotaro, Takéo Takahashi, Hiroyuki Nakamura, et al.. (1998). Abnormal physiological conditions in acute schizophrenic patients on emergency admission: dehydration, hypokalemia, leukocytosis and elevated serum muscle enzymes. European Archives of Psychiatry and Clinical Neuroscience. 248(4). 180–188. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact